Literature DB >> 7342284

Effects of antibiotic-diuretic interactions in the guinea pig model of ototoxicity.

R E Brummett.   

Abstract

The guinea pig model has been useful for estimating quantitatively the ototoxic effects of many different drugs. Our model utilizes measures of the Preyer pinna reflex, the alternating current cochlear potential and sensory hair-cell morphology to access drug effects. The principle pathophysiologic lesion of aminoglycoside-induced permanent ototoxicity appears to be sensory hair-cell loss in the organ of Corti. Aminoglycoside antibiotics were found to interact with loop-inhibiting diuretics, and the augmented ototoxic effects were attributed to hair-cell destruction. The interaction is specific for loop-inhibiting diuretics but not for the aminoglycosides since nonaminoglycoside antibiotics, such as viomycin and polymixin B, interacted similarly. Noninteractive antibiotics include amphotericin B and vancomycin. The absence of ototoxic effects with vancomycin is of interest in view of its broadening clinical utility.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7342284

Source DB:  PubMed          Journal:  Rev Infect Dis        ISSN: 0162-0886


  12 in total

1.  A systemic gentamicin pathway across the stria vascularis.

Authors:  Chun Fu Dai; Peter S Steyger
Journal:  Hear Res       Date:  2007-11-17       Impact factor: 3.208

2.  Cost-ineffectiveness of serum vancomycin levels.

Authors:  B A Cunha; S S Mohan; N Hamid; B P McDermott; P Daniels
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2007-07       Impact factor: 3.267

3.  Comparative analysis of combination kanamycin-furosemide versus kanamycin alone in the mouse cochlea.

Authors:  Keiko Hirose; Eisuke Sato
Journal:  Hear Res       Date:  2010-10-31       Impact factor: 3.208

Review 4.  Drugs affecting the inner ear. A review of their clinical efficacy, mechanisms of action, toxicity, and place in therapy.

Authors:  C H Norris
Journal:  Drugs       Date:  1988-12       Impact factor: 9.546

5.  An experimental study of vancomycin-induced cochlear damage.

Authors:  R A Tange; H L Kieviet; J von Marle; D Bagger-Sjöbäck; W Ring
Journal:  Arch Otorhinolaryngol       Date:  1989

6.  Clarifications regarding bumetanide for neonatal seizures.

Authors:  Kevin J Staley
Journal:  Epilepsia       Date:  2022-05-26       Impact factor: 6.740

7.  The first vancomycin-intermediate Staphylococcus aureus strains isolated from patients in Thailand.

Authors:  Aroonlug Lulitanond; Chulapan Engchanil; Prajuab Chaimanee; Malai Vorachit; Teruyo Ito; Keiichi Hiramatsu
Journal:  J Clin Microbiol       Date:  2009-04-29       Impact factor: 5.948

8.  Aminoglycoside ototoxicity in pediatric patients receiving long-term peritoneal dialysis.

Authors:  B A Warady; L Reed; G Murphy; S Kastetter; E Karlsen; U Alon; S Hellerstein
Journal:  Pediatr Nephrol       Date:  1993-04       Impact factor: 3.714

9.  Uptake of fluorescent gentamicin by vertebrate sensory cells in vivo.

Authors:  C F Dai; D Mangiardi; D A Cotanche; P S Steyger
Journal:  Hear Res       Date:  2006-02-08       Impact factor: 3.208

10.  Potential drug interactions and chemotoxicity in older patients with cancer receiving chemotherapy.

Authors:  Mihaela A Popa; Kristie J Wallace; Antonella Brunello; Martine Extermann; Lodovico Balducci
Journal:  J Geriatr Oncol       Date:  2014-05-10       Impact factor: 3.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.